"Neo-branched" human T-lymphotropic virus antibody Western ink dot method 2.4 reagent - Taiwan Registration b8ac7e4d327a4fec7f0084dbe52adb56
Access comprehensive regulatory information for "Neo-branched" human T-lymphotropic virus antibody Western ink dot method 2.4 reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number b8ac7e4d327a4fec7f0084dbe52adb56 and manufactured by MP BIOMEDICALS ASIA PACIFIC PTE. LTD.. The authorized representative in Taiwan is NEW SCIENTIFIC EQUIPMENT CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
Western ink spots are legally tested for T-lymphotropic virus type 1 and type 2 antibodies in human serum or plasma, and are used for confirmation.
B Hematology, pathology, and genetics
B.4020 Analysis of specific tests
import
Dates and Status
Aug 16, 2012
Jun 04, 2014
May 25, 2018
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ